{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-090182","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2026-08-14T20:35:17+00:00","discovered_at":"2026-08-14T20:40:32.717277+00:00","generated_at":"2026-08-14T20:41:34.250368+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Citius Oncology Q3 FY2026 revenue $1.5M, LYMPHIR demand accelerates","bullets":["Revenue $1.5M for Q3 ended June 30, 2026 (vs $0 prior year); $7.1M for nine months.","Net loss $8.9M ($0.08/share) for Q3; $41.1M ($0.42/share) for nine months, incl. $19.7M one-time CMO cancellation charge.","Institutional vial orders grew 31% sequentially to 926 in Q3; July orders 383 vials, largest month; 44 institutions ordering.","Cash $16.6M; received $9.7M from warrant exercises and $10M from first tranche of $25M senior secured term loan.","Appointed Jonathan Peri as independent director; commercial team expanded to 29 professionals."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-090182","json":"https://secwatch.observer/filing/0001213900-26-090182.json","markdown":"https://secwatch.observer/filing/0001213900-26-090182.md","text":"https://secwatch.observer/filing/0001213900-26-090182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390026090182/0001213900-26-090182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390026090182/ea0302226-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T20:41:34.250368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}